Veracyte Inc (VCYT)
Drugs • Health Care
Percentage
Change
| Mar 14 | Mar 15 | Mar 16 | Mar 17 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 22 | Mar 23 | Feb 24 | Feb 25 | Feb 26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income to Common | 24 | 66 | |||||||||||
Net Income | 24 | 66 | |||||||||||
Profit | 24 | 66 | |||||||||||
Net Income Continuing | 24 | 66 | |||||||||||
Income Tax Expense | -2 | -2 | |||||||||||
Pretax Income | 26 | 68 | |||||||||||
Total Non-operating Income | 10 | 10 | |||||||||||
Operating Income | 16 | 58 | |||||||||||
Total Revenue | 446 | 517 | |||||||||||
Total Costs and Expenses | -430 | -459 | |||||||||||
Cost of Revenue | -136 | -144 | |||||||||||
Operating Expenses | -151 | -157 | |||||||||||
Impairment Expense | -3 | -21 | |||||||||||
Research and Development Expenses | -69 | -71 | |||||||||||
Selling, General & Administrative Expenses | -206 | -211 | |||||||||||
Other Operating Expenses | 128 | 145 |